CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion | +1,779,969 | 1,779,969 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion | +289,198 | 2,069,167 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion | +90,335 | 90,335 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion | +14,677 | 105,012 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Purchase | +47,619 | $21.00 | $1000K | 47,619 |
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion · Preferred Series B Stock | −6,609,027 | 0 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion · Preferred Series B Stock | −335,417 | 0 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion · Preferred Series C Stock | −1,073,793 | 0 | ||
| 2020-12-08 | Presidio Management Group XII, L.L.C. 10% owner | Conversion · Preferred Series C Stock | −54,496 | 0 |
Page 1 of 1 · 9 trades